Nidanilimab

Ask supplier a question | View on supplier's website

Nidanilimab (CAN04) is a fully humanized monoclonal anti-IL1RAP antibody. Nidanilimab blocks IL1α and IL1β signaling and stimulates the immune system to destroy tumor cells. Nidanilimab can be used in the research of non-small cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC).

Supplier	Alfa Cytology
Product #	PC0076
Pricing	1 mg,5 mg, 10 mg, 50mg, 100 mg, inquire

Feedback